The influence of ketanserin, a new S2 receptor antagonist on experimentally induced skeletal muscle myopathy in the rat
- 1 November 1981
- journal article
- research article
- Published by Springer Nature in Virchows Archiv
- Vol. 393 (3) , 265-272
- https://doi.org/10.1007/bf00430826
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- USE OF GENETICALLY DYSTROPHIC ANIMALS IN CHEMOTHERAPY TRIALS AND APPLICATION OF SEROTONIN ANTAGONISTS AS ANTIDYSTROPHIC DRUGSAnnals of the New York Academy of Sciences, 1979
- Experimental serotonin myopathyNeurology, 1977
- Postponement of symptoms of hereditary muscular dystrophy in chickens by 5-hydroxytryptamine antagonistsNature, 1976
- Pathogenesis of Muscular DystrophiesArchives of Neurology, 1976
- Carcinoid MyopathyArchives of Neurology, 1975
- Serotonin-Induced Muscle WeaknessArchives of Neurology, 1974
- Carcinoid myopathy and treatment with cyproheptadine (Periactin)Gut, 1974
- Biochemical and morphological changes induced by Triton-X 100 in skeletal muscle of rats after abdominal aorta ligationCellular and Molecular Life Sciences, 1973
- Considerations About a Possible Role Played by Connective Tissue Proliferation and Vascular Disturbances in the Pathogenesis of Progressive Muscular DystrophyEuropean Neurology, 1968
- Changes of oxygen tension in brain and somatic tissues induced by vasodilator and vasoconstrictor drugsProceedings of the Royal Society of London. B. Biological Sciences, 1961